Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

NCT01254578

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

NCT01399840

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +24 more
Locations: Indiana University Simon Cancer Center Indianapolis, Indiana, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

University of Wisconsin Madison, Wisconsin, United States

University College London London, United Kingdom

View Trial Details

Completed

Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01369849

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Siouxland Regional Cancer Center Sioux City, Iowa, United States

Mercy Medical Center-Sioux City Sioux City, Iowa, United States

Saint Luke's Regional Medical Center Sioux City, Iowa, United States

View all 44 locations

View Trial Details

Completed

Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

NCT00988715

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias

NCT01169012

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

NCT00929695

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +11 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy

NCT02013817

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Tiroler Landeskrankenanstalten Ges.M.B.H.; Innere Medizin Abt. Für Hämatologie & Onkologie Innsbruck, Austria

LKH Hochsteiermark; Abt. für Innere Medizin Leoben, Austria

Kh Der Barmherzigen Schwestern; Interne I X Linz, Austria

A.Ö. Krankenhaus Der Elisabethinen Linz; I. Interne Abt. Linz, Austria

View Trial Details

Completed

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00073918

Conditions: Anaplastic Large Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00244985

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)

NCT01653717

Conditions: Advanced Cancers, Chronic Disease, Disease Attributes, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions